Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Filings indexed 445 across all filing types
Latest filing 2023-06-10 Regulatory Filings
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
Dear Sir/Madam, With reference to the above captioned subject, and in continuation to our Outcome of Board Meeting held on Saturday, 10th June, 2023, the Board has appointed Mr. LAKSHMI ....
Regulatory Filings
2023-06-10 English
Dear Sir/Madam, This is to inform that Board of Directors of the Company at its meeting held on Saturday, 10th June, 2023 at 05:30 P.M. at the corporate office of the company at 304, 3rd ....
Regulatory Filings
2023-06-10 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Research Labs LLP
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the sale of shares by a promoter entity (ACESO RESEARCH LABS LLP) in Macro International Limited, including before and after shareholding percentages, mode of sale, and dates. The document is addressed to the Bombay Stock Exchange and is a formal notification of changes in shareholding by a promoter. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not an annual report, earnings release, or any other financial report, nor is it a proxy or voting result announcement. It is a regulatory disclosure specific to shareholding changes by a major shareholder/promoter under SEBI regulations.
2023-06-10 English
Dear Sir/Madam, This is to inform you that the Company has received disclosures from ACESO RESEARCH LABS LLP, Promoter of the Company under Regulation 7(2) of SEBI (Prohibition of Insider ....
Regulatory Filings Classification · 100% confidence The document is a disclosure under Regulation 7(2)(b) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. It contains details of share transactions by a promoter (ACESO RESEARCH LABS LLP) involving sale of equity shares of Macro International Limited. The document includes Form C, which is a continual disclosure form for insider trading regulations. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure about insider trading transactions, not a financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-06-09 English
Dear Sir / Madam, Pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-05-31 English
Dear Sir/Madam, With reference to the subject captioned above and in compliance with the requirements of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.